Article
p53 mutation and tamoxifen resistance in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Oct 1995
Elledge R M, Lock-Lim S, Allred D C, Hilsenbeck S G, Cordner L
Abstract excerpt
A substantial portion of patients with estrogen receptor-positive breast cancer fail to respond to estrogen depletion or to the antiestrogen tamoxifen. The molecular changes that lead to tamoxifen resistance and estrogen-independent growth are unknown. To test the hypothesis that a p53 mutation could result in tamoxifen resistance and estrogen-independent growth, the MCF-7 cell line was transfected with p53 cDNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
